August 22, 2012 - 6:40am
Srikanth Venkatraman and his team at Merck & Co. are the recipients of the 2012 Heroes of Chemistry Award for developing the chronic hepatitis C drug Victrelis®. His research team is one of three scientific teams to be granted this prestigious ACS award. Detailed information found here.